From: Cysticlean® a highly pac standardized content in the prevention of recurrent urinary tract infections: an observational, prospective cohort study
Baseline (prior to start of treatment)
Month 3
Month 6
(n=20)
Percentage of patients with PCUTIs (previous 3 months)
20 (100%)
10 (50 %)
3 (15 %)
P-value vs. Baseline
0.0016*
<0.0001*
P-value month 6 vs. Month 3
0.0082*